EVAX · Evaxion A/S
Market Cap
$25.60M
Shares
8.34M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$7.53M
+125.1%
FY2025
Net Income
-$7.71M
+27.1%
FY2025
Operating Margin
-122.66%
+317.9pp
FY2025
Diluted EPS
-$4.05
+17.3%
FY2023
Operating Cash Flow
-$6.63M
+48.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| $7.53M | $3.34M | $73K | $0 | — | — | — | — | |
| $9.98M | $10.46M | $11.92M | $17.06M | $19.58M | $10.9M | $8.22M | $3.73M | |
| $6.79M | $7.62M | $10.35M | $8.21M | $6.25M | $5.67M | $2.65M | $1.9M | |
| $615K | $607K | $615K | $571K | $344K | $105K | $81K | $74K | |
| -$9.23M | -$14.73M | -$22.2M | -$25.26M | -$25.83M | -$16.57M | -$10.86M | -$5.63M | |
| -122.66% | -440.55% | -30406.85% | — | — | — | — | — | |
| -$8.62M | -$14.13M | -$21.58M | -$24.69M | -$25.49M | -$16.46M | -$10.78M | -$5.55M | |
| $4M | $3.12M | $1.68M | $1.51M | $915K | $223K | $1.22M | $719K | |
| -$8.62M | -$11.36M | -$22.92M | -$23.94M | -$24.71M | -$16.58M | -$12.02M | -$6.27M | |
| -$908K | -$788K | -$790K | -$772K | -$178K | -$1.56M | -$825K | -$735K | |
| -$7.71M | -$10.57M | -$22.13M | -$23.17M | -$24.53M | -$15.02M | -$11.2M | -$5.54M | |
| -102.38% | -316% | -30308.22% | — | — | — | — | — | |
| USD/shares | -$0.02 | -$0.20 | -$0.81 | -$0.98 | -$6.30 | -$48.50 | -$40.50 | — |
| USD/shares | — | — | -$4.05 | -$4.90 | -$6.30 | -$48.50 | -$40.50 | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Key facts
CIK
1828253
CUSIP
29970R303
13F (30d)
14 filings
14 filers
Visit website
Investor relations